期刊文献+

阴阳因子-1表达与乳腺癌复发转移相关性的研究 被引量:3

Research about the role of YY1 in recurrence and metastasis of breast cancer
原文传递
导出
摘要 目的:探讨正常乳腺组织、乳腺癌原发病灶及乳腺癌复发转移灶中阴阳因子-1(YY1)的表达及其临床意义。方法:采用免疫组织化学SP法检测56例乳腺癌原发病灶及其对应的复发后二次手术的乳腺癌转移灶,以及20例正常乳腺组织中YY1的表达情况,并分析其与ER、PR、c-erbB-2、Ki-67和p53等多个乳腺癌相关因子及临床病理参数的关系。结果:乳腺癌复发转移灶中,YY1的阳性表达率为78.6%(44/56),显著高于乳腺癌原发病灶的51.8%(29/56)及正常乳腺组织的25.0%(5/20),差异有统计学意义,P<0.05。YY1的表达与乳腺癌组织学分级、TNM分期、腋窝淋巴结转移及复发部位相关(P<0.05),而与患者的年龄、肿瘤大小无关,P>0.05;YY1的表达与ER表达呈负相关(P<0.05),与c-erbB-2和Ki-67表达呈正相关(P<0.05),而与PR和p53表达无明显的相关性,P>0.05。结论:YY1的高表达预示着肿瘤具有较高的侵袭性和转移性,YY1有望成为乳腺癌治疗的新靶点。 OBJECTIVE: Measuring the expression of YinYang-1 (YY1) in normal breast tissues, primary breast cancer lesions and metastasis lesions of breast cancer. To study the correlation of ER, PR, c-erbB-2, Ki-67, p53 and YY1 in order to investigate the role of YY1 in the metastasis of breast cancer. METHODS: The expression of YY1 was detected in primary breast cancer tissues, metastasis tissues from 56 breast cancer patients and normal breast tissues from 20 patients with benign breast diseases by immunohistochemical staining. Analyzing the expression of YY1 to clinical characteristics. RESULTS: The positive rate of YY1 in metastasis lesions of breast cancer was 78. 6% (44/56), it was significantly higher than that in primary breast cancer lesions 51.8% (29/56)and normal breast tissues 25.0% (5/20, P〉0.05). There was a positive correlation between breast cancer tissue grades, TNM, axillary lymph node metastasis,position of metastasis and the expression of YYI(P〉0.05) ,there was no correlation between age, the size of tumor and the expression of YY1 (P〉0.05). YY1 had a negative correlation with ER(P〉0.05), a positive correlation with c-erbB-2, Ki-67, and no correlation with PR, p53 (P〉0.05). CONCLUSION: YY1 plays an important role in the development of breast cancer, promotes the metastasis of breast cancer and would become a new target point of breast cancer.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第13期966-969,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30970806) 教育部博士点基金(200802260011) 黑龙江省科技计划项目(WB08B03)
关键词 乳腺肿瘤 阴阳因子-1 复发转移 免疫组织化学 breast neoplasms YinYang-1 metastasis immunohistochemistry
  • 相关文献

参考文献13

  • 1Allouche A, Nolens G, Tancredi A, et al. The combined immunodetection of AP-2 alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumours[J]. Breast Cancer Res, 2008,10 (1) : R9.
  • 2Gordon S, Akopyan G,Garhan H, et al. Transcription factor YY1 : structure,function,and therapeutic implications in cancer biology[J]. Oncogene, 2006,25(8) : 1125-1142.
  • 3Sui G,Affarel B,Shi Y,et al. Yin Yang 1 is a negative regulator of p53[J]. Cell, 2004, 117(7) :859-872.
  • 4Caretti G, Di Padova M, Micales B, et al. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation [J]. Genes Dev, 2004, 18 (21) : 2627- 2638.
  • 5Santiago FS, Ishii H, Shaft S,et al. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4 cyelin D1 assembly[J]. CircRes, 2007,101(2):146-155.
  • 6De Nigris F, Zanella L, Cacciatore F, et al. YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma[J]. BMC Cancer, 2011,2 ( 11 ) : 472.
  • 7Lee MH, Lahusen T, Wang RH, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation[J]. Oncogene, 2012, 31(1):116-127.
  • 8Yokoyama NN, Pate KT, Sprowl S, et al. A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer [J]. Nucleic AcidsRes, 2010,38(19): 6375-6388.
  • 9Powe DG, Akhtar G, Habashy HO, et al. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene tran scription in breast cancers with discordant HER2 gene amplification[J]. Breast Cancer Res,2009,11(6):R90.
  • 10王湛博,赵坡,李向红.乳腺浸润性导管癌c-erbB-2等生物标志表达及其临床病理意义[J].中华肿瘤防治杂志,2009,16(14):1074-1078. 被引量:6

二级参考文献56

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2姜大庆,赵林,龙飞,张斌.乳腺癌新辅助化疗中Ki-67、bcl-2及AI的表达与化疗效果关系的研究[J].中国实用外科杂志,2005,25(4):230-231. 被引量:14
  • 3Hayes D F, Yamauchi H, Broadwater G, et al. Circulating HER-2/ erbB-2/c-neu (HER2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B study 8662[J]. Clin Cancer Res,2001,7(9) :2703-2711.
  • 4Garcia caballero T, Menende Z M D, Vazque z Boquete A,et al. HER-2 status determination in breast carcinomas. A practical approach[J]. Histol Histopathol,2006,21(3) :227- 236.
  • 5Lal P, Tan L K,Chen B. Correlation of HER-2 status with estrogen and progesterone receptors and histologie features in 3 655 invasive breast careinomas[J]. Am J Clin Pathol, 2005 123<4) :541- 546.
  • 6Rastelli F, Crispino S. Factors predictive of response to hormone therapy in breast cancer[J]. Tumori,2008,94(3):370-383.
  • 7Lee K H,Im S A,Oh D Y,et al. Prognostic significance of bcl-2 expression in stage Ⅲ breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy[J]. BMC Cancer, 2007,7 : 63.
  • 8Bieche I, Onody P, Tozhu S, et al. Prognostic valur of ERBB family mRNA expression in breast carcinomas[J]. Int J Cancer, 2003,106(5) :758-765.
  • 9Irvin W J Jr, Carev L A. What is triple-negative breast cancer? [J]. Eur J Cancer, 2008,44(18) :2799-2805.
  • 10Solbach C, Roller M, Budischewski K, et al. EGF-R and HER2/ neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy[J]. J Cancer Res Clin Oneol,2003,129(4) :250- 251.

共引文献21

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部